Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen

Blood

Volumn 119, Issue 23, 2012, Pages 5563-5574

  Stephen, Jillian ^a   Cairns, Lindsay S ^a   Pickford, Wendy J ^a   Vickers, Mark A ^a,b   Urbaniak, Stanislaw J ^b   Barker, Robert N ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CD45RO ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOIMMUNITY; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; BLOOD GROUP; BLOOD GROUP KELL SYSTEM; CARBOXY TERMINAL SEQUENCE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; DNA POLYMORPHISM; FEMALE; GLYCOSYLATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; K ANTIGEN; MEMORY CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 84862517908     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-410324     Document Type: Article

References (39)

1. Urbaniak SJ. Alloimmunity to human red blood cell antigens. Vox Sang. 2002;83(Suppl 1):293-297.
2. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21(1):58-71. (Pubitemid 44881258)
3. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med. 1998;338(12):798-803. (Pubitemid 28135986)
4. Eder AF. Update on HDFN: new information on long-standing controversies. Immunohematology. 2006;22(4):188-195. (Pubitemid 46239723)
5. Metzler B, Fairchild PJ, Wraith DC. MHC binding peptides as therapeutic agents. Clin Exp Rheumatol. 1993;11(Suppl 8):S45-S46. (Pubitemid 23136892)
6. Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol. 1993;5(9):1159-1165. (Pubitemid 23291165)
7. Larché M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med. 2005;11(4 Suppl):S69-S76.
8. Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang. 1997;73(1):1-11. (Pubitemid 27363953)
9. Lee S, Wu X, Reid M, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood. 1995;85(4):912-916.
10. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331-360. (Pubitemid 23115011)
11. Elson CJ, Barker RN. Helper T cells in antibody-mediated, organ-specific autoimmunity. Curr Opin Immunol. 2000;12(6):664-669.
12. Barker RN, Hall AM, Standen GR, Jones J, Elson CJ. Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood. 1997;90(7):2701-2715. (Pubitemid 27413480)
13. Stott LM, Barker RN, Urbaniak SJ. Identification of alloreactive T-cell epitopes on the Rhesus D protein. Blood. 2000;96(13):4011-4019.
14. Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol. 1999;11(10):1625-1634. (Pubitemid 29481729)
15. Muller U, Akdis CA, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998;101(6 Pt 1):747-754.
16. Wang H, Yang J, Jin L, et al. Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides. Immunol Invest. 2009;38(8):690-703.
17. Worm M, Lee HH, Kleine-Tebbe J, et al. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J Allergy Clin Immunol. 2011;127(1):89-97.
18. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7(8):585-598. (Pubitemid 47123554)
19. Barker RN, Elson CJ. Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro. Eur J Immunol. 1994;24(7):1578-1582. (Pubitemid 24203764)
20. Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN. Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood. 2002;100(13):4529-4536. (Pubitemid 35429694)
21. Devereux G, Hall AM, Barker RN. Measurement of T-helper cytokines secreted by cord blood mononuclear cells in response to allergens. J Immunol Methods. 2000;234(1-2):13-22. (Pubitemid 30084794)
22. Akbar AN, Terry L, Timms A, Beverley PC, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol. 1988;140(7):2171-2178. (Pubitemid 18098471)
23. Smith SH, Brown MH, Rowe D, Callard RE, Beverley PC. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology. 1986;58(1):63-70. (Pubitemid 16120932)
24. Hall AM, Cairns LS, Altmann DM, Barker RN, Urbaniak SJ. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood. 2005;105(5):2175-2179. (Pubitemid 40731810)
25. Ellmerich S, Mycko M, Takacs K, et al. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J Immunol. 2005;174(4):1938-46. (Pubitemid 40223934)
26. Sukati H, Watson HG, Urbaniak SJ, Barker RN. Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood. 2007;109(10):4528-4538. (Pubitemid 46743424)
27. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001;17(12):1236-1237. (Pubitemid 33735355)
28. Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood. 2010;115(19):3989-3996.
29. Savalonis JM, Kalish RI, Cummings EA, Ryan RW, Aloisi R. Kell blood group activity of gram-negative bacteria. Transfusion. 1988;28(3):229-232.
30. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389-3402. (Pubitemid 27359211)
31. Clapéron A, Rose C, Gane P, Collec E, Bertrand O, Ouimet T. The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell protein. J Biol Chem. 2005;280(22):21272-21283.
32. Faria AM, Weiner HL. Oral tolerance: mechanisms and therapeutic applications. Adv Immunol. 1999;73:153-264. (Pubitemid 29300430)
33. Grewal IS, Moudgil KD, Sercarz EE. Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen. Proc Natl Acad Sci U S A. 1995;92(5):1779-1783.
34. Hall AM, Ward FJ, Shen CR, et al. Deletion of the dominant autoantigen in NZB mice with autoimmune hemolytic anemia: effects on autoantibody and T-helper responses. Blood. 2007;110(13):4511-4517. (Pubitemid 351377818)
35. Corthay A, Backlund J, Broddefalk J, et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol. 1998;28(8):2580-2590. (Pubitemid 28362732)
36. Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding. J Immunol. 1997;158(7):3221-3226. (Pubitemid 127484037)
37. Ishioka GY, Lamont AG, Thomson D, et al. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol. 1992;148(8):2446- 2451.
38. Jensen T, Galli-Stampino L, Mouritsen S, et al. T cell recognition of Tn-glycosylated peptide antigens. Eur J Immunol. 1996;26(6):1342-1349. (Pubitemid 26001071)
39. Sabatos-Peyton CA, Verhagen J, Wraith DC. Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr Opin Immunol. 2010;22(5):609-615.